Safety of Biologics for Psoriatic Patients with Latent Tuberculosis
Liyan Yuan,* Yang Li,* Junjie Lin, Xiuqiu Lin, Bin Yang, Mao-Qiang Man, Xiaohua Wang Dermatology Hospital, Southern Medical University, Guangzhou, People's Republic of China*These authors contributed equally to this workCorrespondence: Xiaohua Wang, Dermatology Hospital,...
Saved in:
Main Authors: | Yuan L (Author), Li Y (Author), Lin J (Author), Lin X (Author), Yang B (Author), Man MQ (Author), Wang X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research on the benefits of mobile medical APP in the management of psoriatic patients treated with biological therapy
by: Min OU, et al.
Published: (2022) -
Psoriasis and COVID-19 Infection Negatively Impact Each Other: An Analysis of 3581 Cases
by: Wang X, et al.
Published: (2023) -
Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
by: Simone Ribero, et al.
Published: (2019) -
Aspectos biológicos, clínicos y epidemiológicos de la tuberculosis latente: Biological, clinical and epidemiological aspects of latent tuberculosis
by: Jorge A Barrios-Payán, et al.
Published: (2010) -
Different biologics for biological-naïve patients with psoriatic arthritis: a systematic review and network meta-analysis
by: Jixia Lin, et al.
Published: (2024)